Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.6B | 13.6B | 13.2B | 12.9B |
Cost of revenue | 3.2B | 3.3B | 3.2B | 3.2B |
Gross profit | 10.4B | 10.2B | 9.9B | 9.7B |
Operating expense | ||||
Research & development | 2.4B | 2.8B | 2.4B | 2.4B |
Selling general and admin | 3.1B | 3.5B | 3.1B | 3.1B |
Other operating expenses | 306M | 361M | 785M | 227M |
Operating income | 4.7B | 3.5B | 3.6B | 4.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 270M | 275M | 264M | 246M |
Other income expense | -3M | -183M | -4M | -2M |
Pretax income | 4.4B | 3.3B | 3.4B | 3.8B |
Tax provision | 798M | 465M | 200M | 595M |
Net income | 3.6B | 2.8B | 3.2B | 3.2B |
Basic EPS | 1.8 | 1.4 | 1.6 | 1.6 |
Diluted EPS | 1.8 | 1.4 | 1.6 | 1.6 |
Basic average shares | 2.2B | 2.2B | 2.2B | 2.3B |
Diluted average shares | 2.2B | 2.2B | 2.2B | 2.3B |
EBITDA | 5.8B | 5.2B | 5.6B | 5.2B |
Net income from continuing op. | 3.6B | 2.8B | 3.2B | 3.2B |
Minority interests | -3M | -2M | 4M | 0 |
Preferred stock dividends | — | — | — | — |